Hannah E. Fast

ORCID: 0000-0003-4019-8456
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Vaccine Coverage and Hesitancy
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Impact on Reproduction
  • COVID-19 epidemiological studies
  • Respiratory viral infections research
  • Pneumonia and Respiratory Infections
  • Child and Adolescent Health
  • COVID-19 and healthcare impacts
  • Influenza Virus Research Studies
  • Kawasaki Disease and Coronary Complications
  • Viral Infections and Immunology Research
  • Electronic Health Records Systems
  • Data-Driven Disease Surveillance
  • Viral gastroenteritis research and epidemiology
  • Climate Change and Health Impacts
  • COVID-19 Clinical Research Studies
  • Healthcare Policy and Management
  • SARS-CoV-2 detection and testing

Centers for Disease Control and Prevention
2022-2023

Oak Ridge Institute for Science and Education
2023

National Center for Immunization and Respiratory Diseases
2021-2023

Oak Ridge Associated Universities
2023

United States Virgin Islands Department of Health
2023

General Dynamics (United States)
2022

CDC Foundation
2022

Zel Technologies (United States)
2022

Deloitte (United States)
2022

Booz Allen Hamilton (United States)
2022

Higher COVID-19 incidence and mortality rates in rural than urban areas are well documented (1). These disparities persisted during the B.1.617.2 (Delta) B.1.1.529 (Omicron) variant surges late 2021 early 2022 (1,2). Rural populations tend to be older (aged ≥65 years) uninsured more likely have underlying medical conditions live farther from facilities that provide tertiary care, placing them at higher risk for adverse outcomes (2). To better understand vaccination between populations, CDC...

10.15585/mmwr.mm7109a2 article EN MMWR Morbidity and Mortality Weekly Report 2022-03-03

<h3>Importance</h3> The number of SARS-CoV-2 infections and COVID-19–associated hospitalizations deaths prevented among vaccinated persons, independent the effect reduced transmission, is a key measure vaccine impact. <h3>Objective</h3> To estimate adults in US. <h3>Design, Setting, Participants</h3> In this modeling study, multiplier model was used to extrapolate from data on stratified by state, month, age group (18-49, 50-64, ≥65 years) US December 1, 2020, September 30, 2021. These...

10.1001/jamanetworkopen.2022.20385 article EN cc-by-nc-nd JAMA Network Open 2022-07-06

COVID-19 vaccine booster doses are safe and maintain protection after receipt of a primary vaccination series reduce the risk for serious COVID-19-related outcomes, including emergency department visits, hospitalization, death (1,2). CDC recommended an updated (bivalent) adolescents aged 12-17 years adults ≥18 on September 1, 2022 (3). The bivalent is formulated to protect against Omicron BA.4 BA.5 subvariants SARS-CoV-2 as well original (ancestral) strain Based data collected during October...

10.15585/mmwr.mm7207a5 article EN MMWR Morbidity and Mortality Weekly Report 2023-02-16
A. Blythe Ryerson Daniel J. Lang Mohammed Alazawi Milagros Neyra Dustin Hill and 95 more Kirsten St. George Meghan Fuschino Emily Lutterloh Bryon Backenson Samuel Rulli Patricia Schnabel Ruppert Jacqueline Lawler Nancy McGraw Andrew Knecht Irina Gelman Jane R. Zucker Enoma Omoregie Sarah Kidd David E. Sugerman Jaume Jorba Nancy Gerloff Terry Fei Fan Ng Adriana Lopez Nina B. Masters Jessica Leung Cara C. Burns Janell Routh Stephanie R. Bialek M. Steven Oberste Eli S. Rosenberg Bridget J. Anderson Noelle Anderson Jed A. Augustine Megan E. Baldwin Kelly M. Schiabor Barrett Ursula Bauer Andrew Beck Hanen Belgasmi Lydia J. Bennett Achal Bhatt Debra Blog Heather Boss Isaac Ravi Brenner Barrett Brister Travis Wayne Brown Tavora Buchman James E. Bullows Kara Connelly Blaise Cassano Christina J. Castro Cynthia Cirillo G. Cone Janine Cory Amina Dasin Adina de Coteau Anny DeSimone Francoise Chauvin Cynthia Dixey Kathleen Dooling Shawn Doss Christopher Duggar Christopher N. Dunham Delia Easton Christina Egan Brian Emery Randall English Nicola Faraci Hannah E. Fast G. Stephanie Feumba N. W. Fischer Stephen A. Flores Ann D. Frolov Halle Getachew Brittany Gianetti Alejandro Godinez Todd Gray William J. Gregg Christina Gulotta Sarah Hamid Tiffany Hammette Rafael Harpaz Lia Haynes Smith Brianna Hanson Elizabeth Henderson Eugene Heslin Alexandra Hess Dina Hoefer Jonathan Hoffman Lyndsey Hoyt Scott Hughes Anna R. Hutcheson Tabassum Z. Insaf Christopher Ionta Stacey Jeffries Miles Anita Kambhampati Haley R. Kappus-Kron Genevieve N. Keys Michael Kharfen Gimin Kim Jenna Knox

§ A VDPV is a strain related to the attenuated live poliovirus contained in OPV.VDPV2s are OPV virus strains that >0.6%divergent (or at least six nucleotide changes) from OPV2 complete VP1 genomic region.https://polioeradication.org/wp-content/uploads/2016/09/ Reporting-and-Classification-of-VDPVs_Aug2016_EN.pdf ¶ The term PV2, referring all serotype 2 polioviruses, used throughout report indicate either confirmed VDPV2 or type Sabin-like genetically Rockland County patient.A one of Sabin...

10.15585/mmwr.mm7144e2 article EN MMWR Morbidity and Mortality Weekly Report 2022-10-28

The Centers for Disease Control and Prevention recommends a COVID-19 vaccine booster dose all persons >18 years of age. We analyzed data from the National Immunization Survey-Adult COVID Module collected during February 27-March 26, 2022 to assess vaccination coverage among adults. used multivariable logistic regression analysis factors associated with vaccination. fully vaccinated adults increased 25.7% in November 2021 63.4% March 2022. Coverage was lower non-Hispanic Black (52.7%),...

10.3201/eid2901.221151 article EN cc-by Emerging infectious diseases 2023-01-01

Although severe COVID-19 illness and hospitalization are more common among older adults, children can also be affected (1). More than 3 million cases of had been reported infants aged <5 years (children) as December 2, 2022 (2). One in four hospitalized with required intensive care; 21.2% COVID-19-related multisystem inflammatory syndrome (MIS-C) occurred 1-4 years, 3.2% MIS-C <1 year (1,3). On June 17, 2022, the Food Drug Administration issued an Emergency Use Authorization (EUA) Moderna...

10.15585/mmwr.mm7207a4 article EN MMWR Morbidity and Mortality Weekly Report 2023-02-16

Vaccination against SARS-CoV-2 (the virus that causes COVID-19) is highly effective at preventing hospitalization due to infection and booster additional primary dose COVID-19 vaccinations increase protection (1-3). During August-November 2021, a series of Emergency Use Authorizations recommendations, including those for an immunocompromised persons aged ≥18 years, were approved because reduced immunogenicity in persons, waning vaccine effectiveness over time, the introduction transmissible...

10.15585/mmwr.mm7050e2 article EN MMWR Morbidity and Mortality Weekly Report 2021-12-10

We analyzed first-dose coronavirus disease vaccination coverage among US children 5-11 years of age during November-December 2021. Pediatric varied widely by jurisdiction, group, and race/ethnicity, lagged behind for adolescents aged 12-15 the first 2 months vaccine rollout.

10.3201/eid2805.220166 article EN cc-by Emerging infectious diseases 2022-03-01

Immunizations are an important tool to reduce the burden of vaccine preventable diseases and improve population health.1 High-quality immunization data is essential inform clinical public health interventions respond outbreaks vaccine-preventable diseases. To track COVID-19 vaccines vaccinations, CDC established integrated network that included vaccination provider systems, information exchange pharmacy dialysis ordering electronic records, tools support mass clinics. All these systems...

10.1016/j.vaccine.2023.12.005 article EN cc-by-nc-nd Vaccine 2023-12-14

To identify demographic factors associated with delaying or not receiving a second dose of the 2-dose primary mRNA COVID-19 vaccine series, we matched 323 million single Pfizer-BioNTech (https://www.pfizer.com) and Moderna (https://www.modernatx.com) administration records from 2021 determined whether doses were delayed missed. We used 2 sets logistic regression models to examine factors. Overall, 87.3% recipients received timely (≤42 days between first dose), 3.4% (>42 9.4% missed dose....

10.3201/eid2808.220557 article EN cc-by Emerging infectious diseases 2022-07-21

Background In the United States, national ecological studies suggest a positive impact of COVID-19 vaccination coverage on outcomes in adults. However, program children remains unknown. To determine association with U.S. case incidence, emergency department visits, and hospital admissions for pediatric populations during Delta Omicron periods. Methods We conducted an analysis among aged 5–17 compared incidence rate ratios (RRs) cases, by vaccine coverage, jurisdictions highest quartile as...

10.1371/journal.pone.0276409 article EN public-domain PLoS ONE 2022-12-09

Abstract A tree model identified adults age ≤34 years, Johnson &amp; primary series recipients, people from racial/ethnic minority groups, residents of nonlarge metro areas, and those living in socially vulnerable communities the South as less likely to be boosted. These findings can guide clinical/public health outreach toward specific subpopulations.

10.1093/ofid/ofac446 article EN cc-by-nc-nd Open Forum Infectious Diseases 2022-09-01

Abstract Background On July 18, 2022, a case of paralytic polio was reported in person from Rockland County, New York. In August the proportion children County with 3 doses vaccine by age two 60.3%. That month, York State, and CDC initiated campaign to conduct physician-mediated patient outreach improve Inactivated Polio Vaccine (IPV) coverage County. Methods We contacted 38 Vaccines for Children enrolled providers, serving patients aged 3-60 months who were overdue vaccinations, send...

10.1093/ofid/ofad500.117 article EN cc-by Open Forum Infectious Diseases 2023-11-27

Abstract Background In the United States, national ecological studies suggest a positive impact of COVID-19 vaccination coverage on outcomes in adults. However, program children remains unknown. To determine association with U.S. case incidence, emergency department visits, and hospital admissions for pediatric populations during Delta Omicron periods. Methods We conducted an analysis among aged 5–17 compared incidence rate ratios (RRs) cases, by vaccine coverage, jurisdictions highest...

10.1101/2022.10.07.22280822 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2022-10-10

Background: In the United States, national ecological studies suggest a positive impact of COVID-19 vaccination coverage on outcomes in adults. However, program children remains unknown. To determine association with U.S. case incidence, emergency department visits, and hospital admissions for pediatric populations during Delta Omicron periods.Methods: We conducted an analysis among aged 5–17 compared incidence rate ratios (RRs) cases, by vaccine coverage, jurisdictions highest quartile as...

10.2139/ssrn.4229903 article EN SSRN Electronic Journal 2022-01-01
Coming Soon ...